Wespac Advisors So Cal, LLC Dexcom Inc Transaction History

Wespac Advisors So Cal, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 30, 2019	SELL	$27.84 - $38.92 $8,352 - $11,676	-300 Closed	0 $0
Q3 2018 Oct 22, 2018	BUY	$23.35 - $36.72 $7,005 - $11,016	300 New	300 $42,000
Q2 2018 Jul 13, 2018	SELL	$17.54 - $25.22 $5,262 - $7,566	-300 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	300	300 $21,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Wespac Advisors So Cal, LLC, based on Form 13F filings with the SEC.

Stay updated on Wespac Advisors So Cal, LLC with notifications on news.